Rallybio (RLYB) Invested Capital (2022 - 2026)
Rallybio's Invested Capital history spans 4 years, with the latest figure at $58.0 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 6.0% to $58.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.0 million, a 6.0% decrease, with the full-year FY2025 number at $58.0 million, down 6.0% from a year prior.
- Invested Capital hit $58.0 million in Q4 2025 for Rallybio, down from $63.0 million in the prior quarter.
- Over the last five years, Invested Capital for RLYB hit a ceiling of $169.3 million in Q4 2022 and a floor of $46.0 million in Q2 2025.
- Historically, Invested Capital has averaged $93.6 million across 4 years, with a median of $80.0 million in 2024.
- Biggest five-year swings in Invested Capital: tumbled 42.7% in 2024 and later dropped 6.0% in 2025.
- Tracing RLYB's Invested Capital over 4 years: stood at $169.3 million in 2022, then tumbled by 37.29% to $106.2 million in 2023, then tumbled by 41.94% to $61.7 million in 2024, then decreased by 6.0% to $58.0 million in 2025.
- Business Quant data shows Invested Capital for RLYB at $58.0 million in Q4 2025, $63.0 million in Q3 2025, and $46.0 million in Q2 2025.